These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2731106)

  • 1. Radioimmunodetection of lymph node invasion in prostatic cancer. The use of iodine 123 (123I)-labeled monoclonal anti-prostatic acid phosphatase (PAP) 227 A F(ab')2 antibody fragments in vivo.
    Leroy M; Teillac P; Rain JD; Saccavini JC; Le Duc A; Najean Y
    Cancer; 1989 Jul; 64(1):1-5. PubMed ID: 2731106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunodetection of prostate cancer by 111In-labeled monoclonal antibody against prostatic acid phosphatase.
    Ahonen A; Kairemo K; Karnani P; Heikkilä J; Nurmi M; Teräs M; Lukkarinen O
    Acta Oncol; 1993; 32(7-8):723-7. PubMed ID: 8305218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoscintigraphic evaluation of lymph node involvement in prostatic carcinoma.
    Vihko P; Kontturi M; Lukkarinen O; Martikainen P; Pelliniemi L; Heikkilä J; Vihko R
    Prostate; 1987; 11(1):51-7. PubMed ID: 3309904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial results in man of immunolymphoscintigraphy of cancer of the prostate].
    Teillac P; Leroy M; Rain JD; Bruneau J; Cheval E; Ketels F; Rabaud B; Saccavini JC; Najean Y; Le Duc A
    Ann Med Interne (Paris); 1989; 140(1):20-4. PubMed ID: 2786686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with intra lymphatic administration of 111In-labelled monoclonal antibody PAY 276 for the detection of pelvic nodal metastases in prostatic carcinoma.
    Abdel-Nabi HH; Ortman-Nabi JA; See W; Lee J; Ireton R; Boileau M; Unger MW; Halverson C
    Eur J Nucl Med; 1990; 16(3):149-56. PubMed ID: 2364957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients.
    Polascik TJ; Manyak MJ; Haseman MK; Gurganus RT; Rogers B; Maguire RT; Partin AW
    Cancer; 1999 Apr; 85(7):1586-92. PubMed ID: 10193950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125.
    Lehtovirta P; Kairemo KJ; Liewendahl K; Seppälä M
    Cancer Res; 1990 Feb; 50(3 Suppl):937s-940s. PubMed ID: 2297745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo behavior of 111In-labeled monoclonal anti-prostatic acid phosphatase antibody after intraprostatic and intravenous injections.
    Kairemo KJ; Rannikko S; Nordling S; Savalainen S; Ahonen A; Taavitsainen MJ; Alfthan OS
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):151-5. PubMed ID: 7632761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimaging of lymph node involvement in prostatic carcinoma.
    Kontturi M; Lukkarinen O; Vihko P; Vihko R
    Scand J Urol Nephrol Suppl; 1988; 110():113-7. PubMed ID: 3187398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer.
    Waehre H; Wanderaas EH; Paus E; Fosså SD
    Eur Urol; 1992; 22(1):33-8. PubMed ID: 1385143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution in normal mice of an 111In-labelled prostatic acid phosphatase-specific antibody and its F(ab')2 fragments derivatized site-specifically or via bicyclic diethylenetriaminepentaacetic acid anhydride.
    Perälä M; Vihko P; Södervall M; Heikkilä J; Vihko R
    Eur J Nucl Med; 1990; 16(8-10):621-6. PubMed ID: 2384100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tumour mass and circulating antigen on the biodistribution of 111In-labelled F(ab')2 fragments of human prostatic acid phosphatase monoclonal antibody in nude mice bearing PC-82 human prostatic tumour xenografts.
    Perälä-Heape M; Vihko P; Laine A; Heikkilä J; Vihko R
    Eur J Nucl Med; 1991; 18(5):339-45. PubMed ID: 1936042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of unlabelled monoclonal antibodies on the biodistribution of 111In-labelled anti-prostate-specific acid phosphatase monoclonal antibodies in the mouse model.
    Peräalä-Heape M; Vihko P; Vihko R
    Anticancer Res; 1991; 11(3):1327-31. PubMed ID: 1888168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymph node staging in prostatic carcinoma Lymphography, pedal and intraprostatic lymphoscintigraphy, transcutaneous fine-needle lymph node biopsy and pelvic "guided" lymphadenectomy. Considerations on a series of 20 cases (1 September 1978-31 January 1980)].
    Luciani L; Menichelli E; Fuochi C; Taddei L
    Minerva Med; 1981 Apr; 72(13):789-800. PubMed ID: 7012680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunodetection of prostatic cancer. In vivo use of radioactive antibodies against prostatic acid phosphatase for diagnosis and detection of prostatic cancer by nuclear imaging.
    Goldenberg DM; DeLand FH; Bennett SJ; Primus FJ; Nelson MO; Flanigan RC; McRoberts JW; Bruce AW; Mahan DE
    JAMA; 1983 Aug; 250(5):630-5. PubMed ID: 6345831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of 123I-labelled BCD-F9 and 4C4 monoclonal antibody with dissimilar specificity for breast cancer: implication for the detection limit of immunolymphoscintigraphy in the assessment of axillary lymph node metastases.
    Schatten C; Barrada M; Mandeville R; Enzelsberger H; Angelberger P; Czerwenka K; Kubista E; Pateisky N
    Nucl Med Commun; 1994 Jun; 15(6):422-9. PubMed ID: 8078637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunolymphoscintigraphy for the detection of lymph node metastases from breast cancer.
    Tjandra JJ; Russell IS; Collins JP; Andrews JT; Lichtenstein M; Binns D; McKenzie IF
    Cancer Res; 1989 Mar; 49(6):1600-8. PubMed ID: 2647290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase.
    Goldenberg DM; DeLand FH
    Urol Clin North Am; 1984 May; 11(2):277-81. PubMed ID: 6328719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimaging of the prostate and metastases of prostatic carcinoma with 99mTc-labelled prostatic acid phosphatase-specific antibodies and their Fab fragments.
    Vihko P; Heikkilä J; Kontturi M; Wahlberg L; Vihko R
    Ann Clin Res; 1984; 16(1):51-2. PubMed ID: 6742767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.